Get the Stockscreener App
14.87
0.95%
0.14
Afya Ltd stock is traded at $14.87, with a volume of 202.68K.
It is up +0.95% in the last 24 hours and up +5.76% over the past month.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
See More
Previous Close:
$14.73
Open:
$14.71
24h Volume:
202.68K
Relative Volume:
2.09
Market Cap:
$1.36B
Revenue:
$694.52M
Net Income/Loss:
$142.73M
P/E Ratio:
9.6621
EPS:
1.539
Net Cash Flow:
$166.04M
1W Performance:
+5.69%
1M Performance:
+5.76%
6M Performance:
-0.54%
1Y Performance:
-15.61%
1-Day Range:
$14.69
$15.00
1-Week Range:
$14.04
$15.00
52-Week Range:
$13.00
$18.16
Afya Ltd Stock (AFYA) Company Profile
Name
Afya Ltd
Sector
Industry
Phone
-
Address
-
Compare AFYA vs EDU, TAL, LAUR, GHC, CVSA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AFYA
Afya Ltd
|
14.87 | 1.35B | 694.52M | 142.73M | 166.04M | 1.539 |
EDU
New Oriental Education Technology Group Inc Adr
|
46.34 | 7.07B | 5.39B | 456.61M | 911.26M | 2.6369 |
TAL
Tal Education Group Adr
|
9.48 | 4.96B | 3.02B | 532.43M | 603.71M | 0.9385 |
LAUR
Laureate Education Inc
|
37.12 | 5.11B | 1.74B | 281.99M | 263.59M | 1.8957 |
GHC
Graham Holdings Co
|
1,159.96 | 4.90B | 4.98B | 306.64M | 285.69M | 67.59 |
CVSA
Covista Inc
|
127.53 | 4.23B | 1.91B | 249.68M | 336.28M | 5.9265 |
Afya Ltd Stock (AFYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-26 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-13-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-16-26 | Downgrade | UBS | Buy → Neutral |
| Jan-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-08-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-08-25 | Upgrade | UBS | Neutral → Buy |
| Aug-06-25 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Jul-29-25 | Upgrade | Citigroup | Sell → Neutral |
| Mar-11-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-31-25 | Downgrade | Citigroup | Neutral → Sell |
| Dec-03-24 | Initiated | Goldman | Sell |
| Aug-30-24 | Initiated | UBS | Neutral |
| Jan-29-24 | Initiated | Citigroup | Neutral |
| Jan-22-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-13-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-08-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-21-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-15-21 | Upgrade | UBS | Neutral → Buy |
| Feb-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-28-20 | Upgrade | Goldman | Neutral → Buy |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Aug-19-20 | Initiated | Credit Suisse | Neutral |
| May-20-20 | Downgrade | UBS | Buy → Neutral |
| Mar-20-20 | Upgrade | Itau BBA | Market Perform → Outperform |
| Jan-23-20 | Resumed | BofA/Merrill | Buy |
| Sep-19-19 | Initiated | UBS | Buy |
| Aug-13-19 | Initiated | BofA/Merrill | Buy |
| Aug-13-19 | Initiated | Goldman | Neutral |
| Aug-13-19 | Initiated | Morgan Stanley | Overweight |
| Aug-09-19 | Initiated | JP Morgan | Overweight |
View All
Afya Ltd Stock (AFYA) Latest News
Form 6K Afya Ltd For: 22 June By Investing.com - Investing.com South Africa
Form 6K Afya Ltd For: 22 June - Investing.com UK
J.P. Morgan Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $21 - Moomoo
Afya shareholders ratify 2025 accounts at June 22 AGM - Stock Titan
[6-K] Afya Ltd Current Report (Foreign Issuer) | AFYA SEC FilingForm 6-K - Stock Titan
AFYA Maintained by JP Morgan -- Price Target Lowered to $21.00 - GuruFocus
Afya Is Maintained at Neutral by JP Morgan - Moomoo
Afya Ltd (AFYA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Afya Ltd (AFYA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Afya Ltd (AFYA) Institutional Confidence - TradingKey
Afya Ltd (AFYA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Afya Ltd (AFYA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Afya Ltd (AFYA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Afya Ltd (AFYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Afya Ltd (AFYA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Afya Ltd (AFYA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bertelsmann (AFYA) controls 53.54% of Afya Class A after new buys - Stock Titan
Are Investors Undervaluing Afya (AFYA) Right Now? - Yahoo Finance
Afya Ltd (AFYA) Shares Fall 3.0% -- What GF Score of 86 Tells In - GuruFocus
Afya Ltd (NASDAQ:AFYA) Passes Stringent 'Caviar Cruise' Quality Screen with Exceptional Growth and Value Metrics - ChartMill
Afya Limited (NASDAQ: AFYA) insider sells 43,032 Class A shares in April 2026 - Stock Titan
AFYA vs. APEI: Which Stock Is the Better Value Option? - Yahoo Finance
BofA raises Afya stock price target on tuition strength to $18 - Investing.com
Brazil’s Afya puts AI and ESG at core in 2025 report after best since IPO - Stock Titan
Afya Ltd | 3: Initial statement of beneficial ownership of securities- Gibbon Virgilio Deloy Capobianco - Moomoo
AFYA Technical Analysis & Stock Price Forecast - Intellectia AI
Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors - 富途牛牛
Afya shareholders to review 2025 financial statements at June 22 AGM - Stock Titan
Afya (AFYA) schedules 2026 AGM to approve 2025 financial statements - Stock Titan
Afya Ltd | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Afya (NasdaqGS:AFYA) Valuation Check As Shares Trade Near Recent Levels - Yahoo Finance
Should Value Investors Buy Afya (AFYA) Stock? - Yahoo Finance
Swedbank AB Purchases 119,200 Shares of Afya Limited $AFYA - MarketBeat
Afya (NasdaqGS:AFYA) Valuation Check After Mixed Short Term And Three Year Shareholder Returns - simplywall.st
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know - Yahoo Finance
9 Small-Mid Caps Quietly Compounding Cash - Value The Markets
Key Indicators - Intellectia AI
Income Statement - Intellectia AI
AFYA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AFYA LTD-CLASS A (NASDAQ:AFYA): A Caviar Cruise Quality Screen Standout - ChartMill
AFYA or APEI: Which Is the Better Value Stock Right Now? - Yahoo Finance
Top Dividend Stocks To Consider In May 2026 - simplywall.st
Earnings call transcript: Afya’s Q1 2026 performance shows resilience - Investing.com UK
Afya (AFYA) CEO exercises 59K shares and reports tax-withholding of 16K shares - Stock Titan
[Form 4] Afya Ltd Insider Trading Activity - Stock Titan
Earnings call transcript: Afya’s Q1 2026 performance shows resilience By Investing.com - Investing.com Australia
Afya (AFYA) vice president exercises RSUs and increases direct share stake - Stock Titan
Afya (AFYA) CFO exercises RSUs and withholds 6,463 shares for tax obligations - Stock Titan
Afya (AFYA) vice president exercises RSUs as shares withheld for taxes - Stock Titan
Afya (AFYA) vice president exercises 7,000 RSUs and settles taxes with 1,925 shares - Stock Titan
Afya (AFYA) VP gains 10,200 shares from RSU vesting, holds 35,530 - Stock Titan
Afya Ltd Stock (AFYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):